BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF LEVOCETIRIZINE IN BLOOD PLASMA BY USING RP-HPLC

  • Sweety Khatri Malhotra College of Pharmacy, Badwai, Bhopal, (MP) 462038

Abstract

A rapid, selective, precise and sensitive reverse phase high-performance liquid chromatography method was developed for the quantitative estimation of Levocetirizine Dihydrochloride (LD) in human plasma and pharmaceutical dosage form. Extraction of drug from plasma was done by employing optimized liquid-liquid extraction procedure. The sample was analyzed using acetonitrile: methanol: 20mM ammonium acetate buffer pH-5 (25:55:20 % v/v/v) as mobile phase. Chromatographic separation was achieved on Thermo C-18 column (4.6 x 250mm, 5μ particle size) as stationary phase using isocratic elution (at a flow rate of 1 ml/min). The peak was detected using UV-PDA detector set at 232 nm and the total time for a chromatographic separation was 8 min. The calibration curve obtained was linear (r2= 0.9998) over the concentration range of 2-10 μg/ml. Method was validated for precision, robustness and recovery. The limit of detection and limit of quantitation was 0.0057 and 0.174 µg/ml respectively. There was no significant difference between the amount of drug spiked in plasma and the amount recovered and plasma did not interfere in estimation. Thus, the proposed method is suitable for the analysis of LD in tablet dosage forms and human plasma.


Keywords: RP-HPLC, Levocetirizine Dihydrochloride, Human plasma, Liquid-liquid extraction

Downloads

Download data is not yet available.

Author Biography

Sweety Khatri, Malhotra College of Pharmacy, Badwai, Bhopal, (MP) 462038

Malhotra College of Pharmacy, Badwai, Bhopal, (MP) 462038

References

1. Neil JO. The Merck Index. 13th ed.; Merck Research Laboratories, Merck and Co. Inc., Maryndale, White House Station, New Jersey, 2001.
2. Patil PA, Kothekar MA. Development of safer molecules through chirality, Indian Journal of Medical Sciences, 2006; 60(10): 427-437.
3. Testa B, Trager WF. Racemates versus enantiomers in drug development: dogmatism or pragmatism, Chirality, 1990; 2(3):129-133.
4. Devalia JL, Hanotte F, Baltes E, Vos CD. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers, Allergy, 2001; 56(1):50-57.
5. Grant JA, Riethuisen JM, Moulaert B, Vos CD. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects, Annals of Allergy, Asthma & Immunology, 2002; 88(2): 190-197.
6. Indian Pharmacopoeia, Vol. II, The controller of Publications, Ministry of Health and
Family Welfare: Govt. of India, New Delhi: 2007; p 1290.
7. European Pharmacopoeia, 6.0, Vol. II, EDQM, Council of Europe: Stranbourg, France: 2008; p 1479.
8. Raghu MS, Basavaiah K. Optimized and validated spectrophotometric methods for the determination of levocetirizine in pharmaceuticals based on charge transfer reaction, Journal of the Association of Arab Universities for Basic and Applied Sciences, 2012; 12:33-41.
9. Basavaiah K, Raghu MS, Vinay KB. Simple and rapid spectrophotometric assay of levocetirizine in pharmaceuticals through charge-transfer complexation using chloranilic acid and 2,3-dichloro-5,6-dicyanoquinone as π-acceptors, Bulletin of the Chemical Society of Ethiopia, 2012; 26(3):319-328.
10. Gunasakaran S, Rao N, Arunkumar R, Olaganathan A. Determination of levocetirizine in human plasma by liquid chromatography electrospray tandem mass spectrometry, Biomirror, 2010; 1(3):12-27.
11. Morita MR et al. Determination of levocetirizine in human plasma by liquid chromatography–electrospray tandem mass spectrometry: Application to a bioequivalence study, Journal of Chromatography B, 2008; 862:132-139.
12. Chaitanya Prasad MK, Vidyasagar G, Sambasiva Rao KRS, Induri M, Ramanjeneyulu S. Development of validated liquid chromatographic method for estimation of levocetirizine from pharmaceutical dosage forms, Journal of Applied Pharma Sciences, 2011; 01(10): 95-97.
13. Bhusari VK, Dhaneshwar SR. Application of a stability-indicating TLC method for the quantitative determination of Levocetirizine in pharmaceutical dosage forms, International Journal of Advance Pharma Sciences, 2010; 1:387-394.
14. Prabhu SL, Shirwaikar AA, Shirwaikar A, Kumar CD, Kumar GA. Simultaneous UV spectrophotometric estimation of ambroxol hydrochloride and levocetirizine dihydrochloride, Indian Journal of Pharma Sciences, 2008; 70(2):236-238.
15. Merukar SS, Mhaskar PS, Bavaskar SR, Burade KB, Dhabale PN. Simultaneous spectrophotometric methods for estimation of levocetirizine and pseudoephedrine in pharmaceutical tablet dosage form, Journal of Pharma Sciences and Research, 2009; 1(2):38-42.
16. Choudhari V, Kale A, Abnawe S, Kuchekar B, Gawli V, Patil N. Simultaneous determination of montelukast sodium and levocetirizine dihydrochloride in pharmaceutical preparations by ratio derivative spectroscopy, International Journal of Pharma Tech and Research, 2010; 2(1): 4-9.
17. Smita S, Sharma MC, Kohli DV, Sharma AD. Development and validation of TLC-densitometry method for simultaneous quantification of montelukast sodium and levocetirizine dihydrochloride pharmaceutical solid dosage form, Der Pharmacia Lettre, 2010; 2(1): 489-494.
18. Khedkar AN, Veer SU, Rakh MS, Rao JR. Simultaneous estimation and validation of levocetirizine, pseudoephedrine and ambroxol in bulk and combined tablet dosage form by HPTLC, International Journal of Pharmaceutical Quality Assurance, 2014; 6(1); 24-31.
19. Venkateswari P et al. Development of stability indicating RP-HPLC method for the simultaneous estimation of ambroxol hydrochloride and levocetirizine dihydrochloride, International Journal of Advances in Pharmaceutical Sciences,2012; 2(2): 34-40.
20. Ashok Kumar S, Senthil RM, Perumal P. RP-HPLC method development and validation for simultaneous estimation of montelukast sodium and levocetirizine dihydrochloride, International Journal of Pharmaceutical Research, 2009; 1: 8-12.
21. Ambadas RR, Vaishali SN. Determination of montelukast sodium and levocetirizine dihydrochloride in combined pharmaceutical dosage form by RP-HPLC, Latin American Journal of Pharmacy, 2010; 29(6):1020-1023.
22. Kamarapu SK, Vaijayanthi Bahlul ZEA, Venisetty RK. Development of RP-HPLC method for the analysis of levocetirizine dihydrochloride and ambroxol hydrochloride in combination and its application, International Journal of Pharmaceutical Sciences and Nanotechnology 2010; 3(1): 893-897.
23. Shaikh KA, Patil AT. A stability-indicating LC method for the simultaneous determination of levocetirizine dihydrochloride and pseudoephedrine sulfate in tablet dosage forms, International Journal of Chem Tech Research, 2010; 2(1): 454-461.
24. Ishaq BM, Prakash KV, Mohan GK, Muneer S, Ahad HA. RP-HPLC method for simultaneous estimation of levocetirizine dihydrochloride and montelukast sodium in tablets, Indian E-J. Pharma Sciences, 2015; 01(01):18-20.
25. Rao AS, Pavankumar KLNNSVK, Satyanarayana P, Sastrya GS. Validated reverse phase hplc method for the simultaneous estimation of guaifenesin, ambroxol and levocetirizine in pharmaceutical dosage forms, World Journal of Pharmacy and Pharmaceutical Sciences, 2015; 4(9): 1735-1747.
26. Code Q2A-Text on Validation of Analytical Procedure Step-3 Consensus Guideline, 1994, ICH Harmonised Tripartite Guideline.
27. Code Q2B- Validation of Analytical Procedure Methodology Step-4 Consensus Guideline, 1994, ICH Harmonised Tripartite Guideline.
Statistics
34 Views | 30 Downloads
How to Cite
Khatri, S. (2018). BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF LEVOCETIRIZINE IN BLOOD PLASMA BY USING RP-HPLC. Journal of Drug Delivery and Therapeutics, 8(5-s), 288-292. https://doi.org/10.22270/jddt.v8i5-s.1977
Section
Research